Toggle navigation
Home
Search
Services
Blog
Contact
About
Improved Formulations for Anti-Tuberculosis Drugs
Lu, Enxian
Search grants from Enxian Lu
Search grants from
Share this grant:
:
:
Abstract
Funding
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis
Polynucleotide High Performance Affinity Chromatography
Oxygen Activation by Non Heme Fe Proteins
Pet Scanner - Brain Model PC2048-15
Structural Studies of Proteins by Fluorine NMR
Recently added grants:
The Colorado Pragmatic Research in Health Conference (COPRH): Advancing Pragmatic Science for Health Services Research
Mechanogenetic regulation of engineered tissues
Biological Signature and Safety of an Immunomodulatory Probiotic Intervention of Veterans with PTSD
Cancer Center Support Grant
Regulation of ER-beta Signaling in Carcinogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase I (N43)
Project #
272201300025C-0-0-1
Application #
8745836
Study Section
Project Start
2013-09-30
Project End
2014-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2013
Total Cost
$224,284
Indirect Cost
Comments
Be the first to comment on this grant